LFMD Stock Overview
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
LifeMD, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$10.82 |
| 52 Week High | US$12.01 |
| 52 Week Low | US$1.40 |
| Beta | 1.42 |
| 1 Month Change | -2.17% |
| 3 Month Change | 84.33% |
| 1 Year Change | 543.93% |
| 3 Year Change | 11.32% |
| 5 Year Change | 1,342.67% |
| Change since IPO | 188.53% |
Recent News & Updates
Is LifeMD (NASDAQ:LFMD) Using Debt Sensibly?
Apr 25
Even With A 29% Surge, Cautious Investors Are Not Rewarding LifeMD, Inc.'s (NASDAQ:LFMD) Performance Completely
Mar 30LifeMD: Results And Guidance Point To Continued Strength In Weight Management Program
Mar 13Recent updates
Is LifeMD (NASDAQ:LFMD) Using Debt Sensibly?
Apr 25Even With A 29% Surge, Cautious Investors Are Not Rewarding LifeMD, Inc.'s (NASDAQ:LFMD) Performance Completely
Mar 30LifeMD: Results And Guidance Point To Continued Strength In Weight Management Program
Mar 13LifeMD's 2024: Striking A Balance Between Rapid Expansion And Sustainability
Jan 22LifeMD: A GLP-1 Play With A Kicker
Jan 11Is LifeMD, Inc. (NASDAQ:LFMD) Potentially Undervalued?
Jan 05Take Care Before Jumping Onto LifeMD, Inc. (NASDAQ:LFMD) Even Though It's 34% Cheaper
Jan 05Does This Valuation Of LifeMD, Inc. (NASDAQ:LFMD) Imply Investors Are Overpaying?
Dec 03Investors Still Aren't Entirely Convinced By LifeMD, Inc.'s (NASDAQ:LFMD) Revenues Despite 38% Price Jump
Apr 17Analysts Are Betting On LifeMD, Inc. (NASDAQ:LFMD) With A Big Upgrade This Week
Nov 17LifeMD launches at-home screening kits for breast, colon cancers
Sep 14LifeMD Non-GAAP EPS of -$0.22 beats by $0.01, revenue of $30.5M misses by $1.45M
Aug 11LifeMD CEO Justin Schreiber - Disrupting Healthcare With Telemedicine
Jan 10LifeMD: 4 Reasons You Should Avoid This Stock
Sep 29LifeMD: Telehealth Growth Spectacular
Sep 17LifeMD: 'Actual, Hard Numbers' Keep Us Bullish
Jul 13Two class-action shareholder suits against LifeMD dropped
May 28LifeMD (LFMD) Investor Presentation - Slideshow
May 01Shareholder Returns
| LFMD | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | 6.0% | -0.8% | 1.0% |
| 1Y | 543.9% | -9.6% | 21.9% |
Return vs Industry: LFMD exceeded the US Healthcare Services industry which returned -8.1% over the past year.
Return vs Market: LFMD exceeded the US Market which returned 24.9% over the past year.
Price Volatility
| LFMD volatility | |
|---|---|
| LFMD Average Weekly Movement | 9.5% |
| Healthcare Services Industry Average Movement | 9.7% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: LFMD's share price has been volatile over the past 3 months.
Volatility Over Time: LFMD's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 209 | Justin Schreiber | lifemd.com |
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men’s telehealth brand that provides access to virtual medical treatment for a variety of men’s health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more.
LifeMD, Inc. Fundamentals Summary
| LFMD fundamental statistics | |
|---|---|
| Market cap | US$436.76m |
| Earnings (TTM) | -US$23.70m |
| Revenue (TTM) | US$152.55m |
2.9x
P/S Ratio-18.4x
P/E RatioIs LFMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LFMD income statement (TTM) | |
|---|---|
| Revenue | US$152.55m |
| Cost of Revenue | US$18.90m |
| Gross Profit | US$133.65m |
| Other Expenses | US$157.35m |
| Earnings | -US$23.70m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 08, 2024
| Earnings per share (EPS) | -0.59 |
| Gross Margin | 87.61% |
| Net Profit Margin | -15.54% |
| Debt/Equity Ratio | 328.0% |
How did LFMD perform over the long term?
See historical performance and comparison